Accuracy and Predictive Values for Colorectal Cancer of Quantitative FIT in Symptomatic Patients in Primary Care
1 other identifier
observational
2,500
1 country
1
Brief Summary
The aim of this study is to determine accuracy and predictive values for colorectal cancer of a faecal quantitative immunochemical test (FIT) in unselected symptomatic patients presenting in primary care. Main reference test will be linkage to a nationwide colorectal cancer registry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2021
CompletedFirst Submitted
Initial submission to the registry
December 1, 2021
CompletedFirst Posted
Study publicly available on registry
December 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedDecember 14, 2021
November 1, 2021
2 years
December 1, 2021
December 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colorectal cancer
Linkage to cancer registry
2 years
Eligibility Criteria
Patients aged ≥ 40 years presenting in primary care with symptoms associated with colorectal cancer prompting their GP to take actions are eligible. This involves referral for any endoscopic or radiological examination of the large bowel, laboratory testing, including faecal occult blood test according to local routines, or clinical follow-up within soon. Both urgent referrals and patients planned for at least initial management in primary care are eligible, ie there will be no attempt to delimitate the study population based on any categorization of symptoms into "alarm" and "non-alarm" symptoms. The study population will be defined by primary care physicians´ clinical reasoning and assessment of colorectal cancer as a (more or less) possible diagnosis at the unique consultation.
You may qualify if:
- Patients presenting in primary care with symptoms associated with colorectal cancer prompting their GP to take actions are eligible.
You may not qualify if:
- Referral for bowel examination for other reasons than symptoms. Not able to understand the instructions for participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Örebro Countylead
- Region Jämtland Härjedalencollaborator
- Region Östergötlandcollaborator
- Uppsala County Council, Swedencollaborator
- Dalarna County Council, Swedencollaborator
- Landstinget i Värmlandcollaborator
Study Sites (1)
Skebäcks VC
Örebro, 702 15, Sweden
Related Publications (1)
Loov A, Hogberg C, Lilja M, Theodorsson E, Hellstrom P, Metsini A, Olsson L. Diagnostic accuracy for colorectal cancer of a quantitative faecal immunochemical test in symptomatic primary care patients: a study protocol. Diagn Progn Res. 2022 Aug 18;6(1):16. doi: 10.1186/s41512-022-00129-7.
PMID: 35978403DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louise Olsson, MD, PhD
Region Örebro län, Camtö
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
December 1, 2021
First Posted
December 14, 2021
Study Start
May 20, 2021
Primary Completion
June 1, 2023
Study Completion
June 1, 2024
Last Updated
December 14, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share